BVT948 is primarily utilized in biochemical research as a potent and selective inhibitor of protein tyrosine phosphatases (PTPs), particularly targeting the enzyme PRL-3. Its application is significant in cancer studies, where it is used to investigate the role of PRL-3 in tumor growth, metastasis, and cell signaling pathways. By inhibiting PRL-3, BVT948 helps researchers understand the mechanisms underlying cancer progression and evaluate potential therapeutic strategies. Additionally, it serves as a valuable tool in studying phosphatase-related cellular processes and their implications in various diseases.